D-0463-2022 Class II Ongoing
FDA drug recall D-0463-2022 was initiated by Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy on December 21, 2021 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 57,994 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- February 9, 2022
- Initiation Date
- December 21, 2021
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 57,994 vials
Product Description
Medroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single Dose Vial, RX Only, Ideal Pharmacy, 2333 Morris Ave, Union, NJ 07083
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
nationwide in the USA
Code Information
All lots within expiry